

1. 59467-69-5
2. 8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3h-benzo[f]imidazo[1,5-a][1,4]diazepine
3. Wp58xdp3tt
4. 8-chloro-3a,4-dihydro-6-(2-fluorophenyl)-1-methyl-3h-imidazo[1,5-a][1,4]benzo-diazepine
5. 3h-imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-3a,4-dihydro-1-methyl-
6. 8-chloro-6-(2-fluorophenyl)-3a,4-dihydro-1-methyl-3h-imidazo(1,5-a)(1,4)benzodiazepine
7. (3ars)-8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3h-imidazo[1,5-a][1,4]benzodiazepine
8. Reduced Midazolam
9. Unii-wp58xdp3tt
10. Midazolam Impurity I [ep]
11. Schembl2969718
12. Dtxsid60452329
13. Bcp24692
14. Akos015896554
15. Midazolam Impurity I [ep Impurity]
16. Db-072643
17. Ft-0726224
18. (z)-n-(1-(dimethylamino)prop-1-en-2-yl)acetamide
| Molecular Weight | 327.8 g/mol |
|---|---|
| Molecular Formula | C18H15ClFN3 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 327.0938533 g/mol |
| Monoisotopic Mass | 327.0938533 g/mol |
| Topological Polar Surface Area | 28 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 520 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-...
CAS Number : 59467-69-5
End Use API :
End Use API : Midazolam
About the Company : Stellence Pharmscience Private Limited is a company keenly involved in the business of manufacturing Active Pharmaceuticals Ingredients (API), High End Intermediates (HEIN) and Contrast...

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulatio...
Contact Us!